Board Meeting18 May 2026, 03:06 pm
Genomic Valley Biotech Board Meeting on May 29, 2026
AI Summary
Genomic Valley Biotech Ltd has scheduled a Board of Directors meeting on May 29, 2026, to consider and approve the audited financial results (standalone) for the quarter and year ended March 31, 2026. The trading window for dealing in the company's securities is closed from April 01, 2026, until 48 hours after the results are made public.
Key Highlights
- Board meeting scheduled for May 29, 2026, to approve audited financial results.
- Financial results are for the quarter and year ended March 31, 2026.
- Trading window closed from April 01, 2026, until 48 hours post result announcement.
- Consideration of any other matter with the chairman's permission.
Price Impact
More from GVBL